On February 13, 2024, Allarity Therapeutics, Inc. closed the transaction.The company raised a senior convertible promissory note for the gross proceeds of $400,000 in its second and final tranche.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.754 USD | -1.66% | -38.70% | -93.16% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-93.16% | 237K | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- ALLR Stock
- News Allarity Therapeutics, Inc.
- Allarity Therapeutics, Inc. announced that it has received $0.8 million in funding from 3i, LP